SYDNEY-BASED pharmaceutical business, Link Healthcare, has confirmed it can supply UK registered Fluoxetine 20mg capsules (Strides Pharma) to cover shortages of Prozac 20 fluoxetine 20mg and Lovan fluoxetine 20mg.
The temporary approval under Section 19A of the Therapeutic Goods Act, has been granted until 30 Apr 2021.
The product has been approved for major depression, obsessive compulsive disorder and premenstrual dysphoric disorder.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Nov 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Nov 20
